Ex Parte Au-Young et al - Page 3


              Appeal No. 2003-1817                                                                  Page 3                 
              Application No. 09/501,714                                                                                   

              judicially created doctrine of obviousness-type double patenting over the claims of U.S.                     
              Patent Nos. 5,922,567 or 6,001,598.  We reverse the written description rejection and                        
              affirm the obviousness rejection and obviousness-type double patenting rejections.  In                       
              addition, we make a new ground of rejection under 37 CFR § 1.196(b).                                         
                                                       Discussion                                                          
              1.  Written description.                                                                                     
                     The examiner considers that claims 45, 47-49, 52, 54-56 and 66-68 do not                              
              comply with the written description requirement of 35 U.S.C. § 112, first paragraph,                         
              since:                                                                                                       
                     Allelic variants are alternate forms of a gene which have at least one                                
                     mutation in the nucleotide sequence which may result in mRNAs                                         
                     (polypeptides) with altered function.  With regard to a naturally-occurring                           
                     human polynucleotide sequence variant, there is no description in the                                 
                     specification of any mutational site that exist in nature, and there is no                            
                     description of how the structure of SEQ ID NOs: 2 or 4 relates to the                                 
                     structure of any allele including strictly neutral alleles.  The general                              
                     knowledge in the art concerning alleles does not provide any indication of                            
                     how the structure of one allele is representative of unknown alleles.  The                            
                     nature of alleles is that they are variant structures, and in the present state                       
                     of the art the structure of one does not provide guidance to the structure of                         
                     others.                                                                                               
                                                                                                                          
              Examiner’s Answer, page 6.                                                                                   
                     The Federal Circuit discussed the application of the written description                              
              requirement to inventions in the field of biotechnology in University of California v. Eli                   
              Lilly and Co., 119 F.3d 1559, 1568, 43 USPQ2d 1398, 1406 (Fed. Cir. 1997), stating                           
              that “[a] written description of an invention involving a chemical genus, like a description                 
              of a chemical species, ‘requires a precise definition, such as by structure, formula, [or]                   
              chemical name,’ of the claimed subject matter sufficient to distinguish it from other                        
              materials” Id. at 1567, 43 USPQ2d at 1405.  The court also stated that                                       




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007